HomeARTV • NASDAQ
add
Artiva Biotherapeutics Inc
Previous close
$4.39
Day range
$3.94 - $4.56
Year range
$1.47 - $15.49
Market cap
95.58M USD
Avg Volume
4.39M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.81M | 40.89% |
Net income | -21.25M | -19.12% |
Net profit margin | — | — |
Earnings per share | -0.87 | -36.41% |
EBITDA | -22.17M | -42.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 142.36M | 205.79% |
Total assets | 169.39M | 123.14% |
Total liabilities | 20.35M | -59.78% |
Total equity | 149.04M | — |
Shares outstanding | 24.43M | — |
Price to book | 0.72 | — |
Return on assets | -31.62% | — |
Return on capital | -33.05% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -21.25M | -19.12% |
Cash from operations | -22.98M | -67.94% |
Cash from investing | 21.12M | 1,465.75% |
Cash from financing | -72.00K | 95.54% |
Net change in cash | -1.93M | 86.15% |
Free cash flow | -17.14M | -124.87% |
About
Founded
2019
Website
Employees
105
